Home › Obesità › Texas › San Antonio
Studi clinici su Obesità a San Antonio, TX
40 studi su Obesità cercano partecipanti presso sedi a San Antonio e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
In reclutamentoFase 1Volontari sani benvenuti
- Kailera Clinical Site, San Antonio
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
In reclutamentoFase 3
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research, San Antonio
- e altri 1
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
In reclutamentoFase 1
- Endeavor Clinical Trials, San Antonio
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
In reclutamentoFase 3
- Sleep Therapy Research Center, San Antonio
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
In reclutamentoFase 3
- VIP Trials, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
In reclutamentoFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
In reclutamentoFase 3
- IMA Clinical Research San Antonio, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
In reclutamentoFase 3
- IMA Clinical Research San Antonio, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
In reclutamentoFase 3
- Research Site, San Antonio
- Research Site, San Antonio
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
In reclutamentoFase 3
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
In reclutamentoFase 3
- Bandera Family Health Care, San Antonio
- Consano Clinical Research - Shavano Park, Shavano Park · a 12 mi di distanza
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
In reclutamentoFase 3
- IMA Clinical Research San Antonio, San Antonio
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
In reclutamentoFase 3
- VIP Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Endeavor Clinical Trials, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 3
- AURORA-1 Clinical Site, San Antonio
- AURORA-1 Clinical Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
In reclutamentoFase 3
- AURORA-2 Clinical Site, San Antonio
- AURORA-2 Clinical Site, San Antonio
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
In reclutamentoFase 3
- Pinnacle Clinical Research - San Antonio, San Antonio
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
In reclutamentoFase 2
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
In reclutamentoFase 3
- Pinnacle Clinical Research - South San Antonio, San Antonio
- IMA Clinical Research - San Antonio, San Antonio
- Consano Clinical Research, Shavano Park · a 12 mi di distanza
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
In reclutamentoFase 3
- Sleep Therapy Research Center, San Antonio
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
In reclutamentoFase 3Volontari sani benvenuti
- ACCOMPLISH-2 Research Site, San Antonio
- ACCOMPLISH-2 Research Site, San Antonio
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
In reclutamentoFase 3
- Sleep Therapy Research Center, San Antonio
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- Endeavor Clinical Trials, San Antonio
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
In reclutamentoFase 2
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
In reclutamentoFase 1Volontari sani benvenuti
- ICON, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
In reclutamentoFase 4
- Texas Dermatology and Laser Specialists, San Antonio
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
In reclutamentoFase 3
- Clinical Trials of Texas, San Antonio
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, San Antonio
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
In reclutamentoFase 1Volontari sani benvenuti
- ICON Early Phase Services, LLC, San Antonio
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- VIP Trials, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
In reclutamentoFase 3
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
In reclutamentoFase 1Volontari sani benvenuti
- ICON Early Phase Services, San Antonio
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- University Hospital, San Antonio
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, San Antonio
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
In reclutamentoFase 2
- Flourish Research - San Antonio Medical Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · a 12 mi di distanza
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
In reclutamentoFase 3
- VIP Trials_San Antonio, San Antonio
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
In reclutamentoVolontari sani benvenuti
- South Texas Health Care System, San Antonio, TX, San Antonio
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
In reclutamentoFase 3Volontari sani benvenuti
- Vanda Investigational Site, San Antonio
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
In reclutamentoFase 2
- University of Texas Health Science Center at San Antonio, San Antonio
Studi su Obesità in altre città
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- Washington, DC33 studi
- Orlando, FL31 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
- St. Louis, MO25 studi
Altri studi a San Antonio
- Cancro del polmone non a piccole cellule59 studi
- Cancro colorettale46 studi
- Cancro al seno46 studi
- Cancro metastatico44 studi
- Cancro (tutti i tipi)41 studi
- Diabete di tipo 237 studi
- Sovrappeso34 studi
- Cancro ovarico31 studi
- Cancro pancreatico31 studi
- Cancro alla prostata28 studi
- Cancro dell'endometrio27 studi
- Cancro ai polmoni26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.